Skip to main content
. 2020 Aug 13;8(11):1121–1131. doi: 10.1016/S2213-2600(20)30328-3

Table 2.

Characteristics of the patients on ECMO day 1 according to their endpoint state on July 10, 2020

All patients (N=83) Alive and discharged from the ICU (n=48)* Alive and still in the ICU (n=5) Died (n=30)
Type of ECMO support
Femoral–jugular, venovenous 79 (95%) 47 (98%) 4 (80%) 28 (93%)
Femoral–femoral, venovenous 2 (2%) 0 0 2 (7%)
Femoral–femoral, venoarterial 1 (1%) 0 1 (20%) 0
Femoral–jugular–femoral, venoarterial-venous 1 (1%) 1 (2%) 0 0
29 Fr drainage cannula 57 (69%) 33 (69%) 3 (60%) 21 (70%)
Return cannula
17 Fr 2 (2%) 1 (2%) 0 1 (3%)
19 Fr 21 (25%) 15 (31%) 0 6 (20%)
21 Fr 42 (51%) 21 (44%) 4 (80%) 17 (57%)
23 Fr 18 (22%) 11 (23%) 1 (20%) 6 (20%)
ECMO blood flow L/min 5·1 (4·6–5·5) 5·1 (4·6–5·5) 5·0 (4·0–5·3) 5·1 (4·6–5·5)
Sweep gas flow, L/min 5 (4–6) 5 (4–7) 3·5 (3·0–5) 5 (4–6)
Membrane FmO2 100% (100–100) 100% (100–100) 100% (100–100) 100% (97–100)
Total SOFA score day 1 11 (9–14) 10 (9–12) 11 (9–17) 12 (11–16)
Renal component of the SOFA score of 3 or greater 20 (24%) 7 (15%) 2 (40%) 11 (37%)
Cardiovascular component of the SOFA score of 3 or greater 43 (52%) 20 (42%) 3 (60%) 20 (67%)
Haematological component of the SOFA score of 3 or greater 4 (5%) 1 (2%) 1 (20%) 2 (7%)
Ventilation parameters
FiO2 55 (40–80) 60 (30–80) 40 (30–70) 55 (43–70)
Positive end-expiratory pressure, cm H2O 12 (12–14) 12 (12–14) 12 (12–12) 12 (12–12)
Tidal volume, mL/kg predicted bodyweight 2·5 (1·8–4·2) 2·9 (1·9–4·2) 2·5 (2·3–2·8) 2·2 (1·4–4·2)
Respiratory rate, number per min 20 (20–24) 20 (20–25) 20 (20–24) 20 (20–24)
Plateau pressure, cm H2O 27 (27–30) 27 (24–30) 27 (27–27) 28 (27–30)
Driving pressure, cm H2O 12 (12–14) 12 (12–14) 12 (12–12) 14 (12–15)
Compliance, mL/cm H2O 12·5 (9·0–20·0) 13·3 (9·6–20·1) 15·9 (13·2–16·7) 10·9 (7·7–18·8)
Mechanical power, J/min 6·1 (4·1–11·0) 6·8 (4·5–12·4) 7·1 (5·6–11·1) 6·1 (4·0–9·9)
Ventilatory ratio 0·7 (0·4–1·1) 0·8 (0·5–1·1) 0·6 (0·4–1·0) 0·7 (0·4–1·1)
Ventilation mode
Airway pressure release ventilation/bilevel PAPV 70 (84%) 42 (88%) 4 (80%) 24 (80%)
Volume-assist control ventilation 13 (16%) 6 (13%) 1 (20%) 6 (20%)
Blood gases on ECMO day one
pH 7·40 (7·36–7·47) 7·40 (7·37–7·46) 7·32 (7·29–7·48) 7·41 (7·34–7·48)
PaO2, mm Hg 82 (70–100) 84 (71–101) 79 (72–80) 82 (64–98)
PaCO2, mm Hg 45 (40–50) 47 (40–50) 48 (43–51) 42 (38–47)
SaO2 96% (93–98) 96% (94–98) 96% (94–97) 96% (92–97)
Arterial lactate, mmol/L 1·7 (1·4–2·1) 1·7 (1·4–2·1) 2·1 (1·9–2·1) 1·7 (1·4–2·1)
Laboratory values
Platelets, × 109 cells per L 236 (176–299) 242 (187–286) 375 (175–398) 214 (139–305)
Haemoglobin, g/dL 9·0 (7·9–10·2) 9·6 (8·1–10·6) 7·9 (7·7–10·5) 8·5 (7·9–9·1)
Fibrinogen, g/L 6·7 (5·6–8·1) 7·1 (6·0–8·4) 5·2 (3·1–7·0) 6·4 (5·3–7·9)
d–Dimers, ng/mL§ 6890 (2350–19460) 8065 (2110–19730) 7495 (4502–12710) 5620 (2970–10790)
aPTT ratio 1·3 (1·2–1·6) 1·2 (1·1–1·5) 1·6 (1·2–1·6) 1·4 (1·3–1·8)
Adjuvant therapy on ECMO day 1
Any 70 (84%) 41 (85%) 2 (40%) 27 (90%)
Neuromuscular blockade 70 (84%) 41 (85%) 2 (40%) 27 (90%)
Prone-positioning 7 (8%) 6 (13%) 0 1 (3%)
Inhaled nitric oxide 3 (4%) 1 (2%) 0 2 (7%)
Renal replacement therapy 12 (14%) 4 (8%) 2 (40%) 6 (20%)
Pneumothorax 2 (2%) 1 (2%) 0 1 (3%)
Cardiac arrest 2 (2%) 0 0 2 (7%)

Data are median (IQR) or n (%). aPTT=activated partial thromboplastin time. ECMO=extracorporeal membrane oxygenation. ICU=intensive care unit. FiO2=fraction of inspired oxygen. PaO2=partial pressure of arterial oxygen. PaCO2=partial pressure of arterial CO2. PAPV=positive airway pressure ventilation. SOFA=Sequential Organ-Function Assessment.

*

On July 10, 2020, of the 48 patients discharged from the ICU, 14 were still hospitalised or in a rehabilitation centre and 34 returned home.

On July 10, 2020, of the five patients still in the ICU, one remained on ECMO.

78 patients.

§

63 patients.